Use of exendins and agonists thereof for lowering plasma lipid
US7138375B2 · kind B2 · utility
75Cited by
9References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2004 |
| Grant date | Nov 21, 2006 |
| Priority date | — |
| Expiry date | Dec 30, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods for lowering plasma lipid in an individual in need of or desirous of lowering plasma lipid by administering an amount of an exendin or an exendin agonist analog effective to lower plasma lipid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.